Background illustration for clinical trials search

Mantle Cell Lymphoma Clinical Trials

Browse 73 mantle cell lymphoma clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Sonrotoclax, Rituximab, and Zanubrutinib in Treating Participants With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Mantle Cell Lymphoma

for
Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT06839053

Phase 2, Recruiting

B-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells With Fludarabine and Cyclophosphamide Lymphodepletion for the Treatment of Relapsed or Refractory B-cell Hematologic Malignancies

for
B-Cell Non-Hodgkin Lymphoma,
Location: Jacksonville FL
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06191887

Phase 1, Recruiting

Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia

for
B-Cell Lymphoma, B Acute Lymphoblastic Leukemia,
Location: Pittsburgh PA
Sponsor: John Lister

Sex: All

Age: 18 - 70+

Code: NCT05281809

Phase 2, Recruiting

Optimizing ctDNA-based MRD Assessment in DLBCL, MCL, and FL Patients Undergoing CAR Therapy

for
Follicular Lymphoma, Diffuse Large B Cell Lymphoma,
Location: Palo Alto CA
Sponsor: Adaptive Biotechnologies

Sex: All

Age: 18+

Code: NCT05255354

Recruiting

Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.

for
CLL/SLL, Waldenstrom Macroglobulinemia, Follicular Lymphoma,
Location: Durham NC, Columbus OH, Cincinnati OH,
Sponsor: Newave Pharmaceutical Inc

Sex: All

Age: 18+

Code: NCT04775745

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma

for
Mantle Cell Lymphoma
Location: Chicago IL, Providence RI, Westerly RI, Waterford CT,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 60+

Code: NCT05976763

Phase 3, Recruiting

Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment

for
Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 18+

Code: NCT06784167

Recruiting

DALY II USA/ MB-CART2019.1 for DLBCL

for
Refractory Diffuse Large B Cell Lymphoma (DLBCL),
Location: Boston MA, New Haven CT, New York NY, Baltimore MD,
Sponsor: Miltenyi Biomedicine GmbH

Sex: All

Age: 18+

Code: NCT04792489

Phase 2, Recruiting

Phase 2 Study of BTKi-Rituximab Induction Followed by Glofitamab Consolidation in High Risk Untreated MCL Patients - WINDOW-4 Study

for
Phase 2 Study, MCL, BTKi, Rituximab, Glofitamab
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07257055

Phase 2, Recruiting

A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

for
Lymphoma
Location: New Haven CT, Stony Brook NY, New Brunswick NJ,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT06084936

Phase 3, Recruiting

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

for
Advanced Systemic Mastocytosis (AdvSM),
Location: Boston MA, Charleston SC, Toronto, Atlanta GA,
Sponsor: Cogent Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT04996875

Phase 2, Recruiting

Zanubrutinib and Tafasitamab in Mantle Cell Lymphoma

for
Mantle Cell Lymphoma
Location: Miami FL
Sponsor: Alvaro Alencar, MD

Sex: All

Age: 18+

Code: NCT06029309

Phase 1, Phase 2, Recruiting

Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

for
Mantle Cell Lymphoma, Follicular Lymphoma,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT04223765

Phase 1, Recruiting